Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β.
Darvishi E, Ghamsari L, Leong SF, Ramirez R, Koester M, Gallagher E, Yu M, Mason JM, Merutka G, Kappel BJ, Rotolo JA.
Darvishi E, et al. Among authors: mason jm.
Mol Cancer Ther. 2022 Nov 3;21(11):1632-1644. doi: 10.1158/1535-7163.MCT-21-0962.
Mol Cancer Ther. 2022.
PMID: 36121385
Free PMC article.